LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it has promoted Brian McCollum to President of the Spine Global
Business Unit. Mr. McCollum will continue to serve as the Company's
Chief Financial Officer through November 10, 2012.
During his 11 year tenure with Orthofix, Mr. McCollum has served in
various operational and financial executive roles. Most recently, Mr.
McCollum managed the Company's operating margin improvements and led the
divestiture of the Sports Medicine business, which significantly
deleveraged the Company.
"I am very excited to have Brian take over this important role given his
strong track record of success within the Company," said President and
Chief Executive Officer Robert Vaters. "Brian's operational and
financial experience along with our increased financial flexibility will
allow us to take the Spine Global Business Unit to the next level."
The Company also announced the appointment of Emily Buxton to Interim
Chief Financial Officer, effective November 11, 2012. Ms. Buxton has
been with the Company in various roles of increasing responsibilities
over the past 9 years most recently as the Chief Financial Officer of
the Global Orthopedics Business Unit.
Bryan McMillan, the current President of the Spine Global Business Unit,
has resigned due to family reasons. We appreciate the contributions he
has made to the Company and wish him well.
Forward-Looking Statements:
This communication contains certain forward-looking statements under the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements, which may include statements concerning the projections,
financial condition, results of operations and businesses of Orthofix
and its subsidiaries and are based on management's current expectations
and estimates and involve risks and uncertainties that could cause
actual results or outcomes to differ materially from those contemplated
by the forward-looking statements. The forward-looking statements in
this release do not constitute guarantees or promises of future
performance, and existing and prospective investors are cautioned not to
place undue reliance on these forward-looking statements.
About Orthofix:
Orthofix International N.V. is a diversified, global medical device
company focused on developing and delivering innovative repair and
regenerative solutions to the spine and orthopedic markets. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
and via collaborations with other leading orthopedic product companies.
In addition, Orthofix is collaborating on R&D activities with leading
research and clinical organizations such as the Musculoskeletal
Transplant Foundation, the Orthopedic Research and Education Foundation,
and Texas Scottish Rite Hospital for Children. For more information
about Orthofix, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Director
of Investor Relations and Business Development
markquick@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media